Published in Clin Infect Dis on July 15, 2005
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev (2006) 5.50
Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev (2009) 4.43
Acquired antibiotic resistance genes: an overview. Front Microbiol (2011) 2.80
Pseudomonas aeruginosa: resistance to the max. Front Microbiol (2011) 2.76
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol (2009) 2.73
Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother (2008) 2.70
Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep (2014) 2.40
RecA maintains the integrity of chloroplast DNA molecules in Arabidopsis. J Exp Bot (2010) 1.86
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci U S A (2014) 1.82
Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev (2011) 1.75
Quinolones: action and resistance updated. Curr Top Med Chem (2009) 1.73
Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother (2013) 1.61
Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis (2012) 1.55
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg (2016) 1.55
High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol (2009) 1.52
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol (2014) 1.47
The challenge of developing robust drugs to overcome resistance. Drug Discov Today (2011) 1.43
Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies. Front Microbiol (2012) 1.38
Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar. Antimicrob Agents Chemother (2006) 1.34
Mechanism of quinolone action and resistance. Biochemistry (2014) 1.34
Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis (2008) 1.32
Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother (2007) 1.31
Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care (2015) 1.30
Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant. Biochemistry (2008) 1.27
Antibiotic resistance in Chlamydiae. Future Microbiol (2010) 1.22
Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes. J Clin Microbiol (2008) 1.20
The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep (2009) 1.18
Evaluation of an expanded microarray for detecting antibiotic resistance genes in a broad range of gram-negative bacterial pathogens. Antimicrob Agents Chemother (2012) 1.18
Mechanism of action of and resistance to quinolones. Microb Biotechnol (2008) 1.16
Antimicrobial resistance in hospitals: how concerned should we be? CMAJ (2009) 1.16
A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. J Antimicrob Chemother (2010) 1.15
Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. Eur J Clin Microbiol Infect Dis (2008) 1.14
Quinolone resistance: much more than predicted. Front Microbiol (2011) 1.14
Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. J Clin Microbiol (2012) 1.14
Plasmid-mediated quinolone resistance. Microbiol Spectr (2014) 1.13
Essential bacterial functions encoded by gene pairs. J Bacteriol (2006) 1.12
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother (2009) 1.12
Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front Microbiol (2013) 1.12
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol (2005) 1.11
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother (2009) 1.11
The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother (2014) 1.08
Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. Antimicrob Agents Chemother (2015) 1.06
Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int (2013) 1.05
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophthalmol (2008) 1.04
Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.02
Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor. Antimicrob Agents Chemother (2010) 1.01
Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob Agents Chemother (2013) 1.00
Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci (2015) 1.00
NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy. Antimicrob Agents Chemother (2014) 0.99
A plasmid-borne Shewanella algae Gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae. J Bacteriol (2008) 0.99
NDM-1 Metallo-β-Lactamase and ArmA 16S rRNA methylase producing Providencia rettgeri clinical isolates in Nepal. BMC Infect Dis (2014) 0.99
Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiol (2013) 0.98
Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health (2015) 0.96
Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol (2009) 0.95
The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex. J Bacteriol (2008) 0.95
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis (2012) 0.95
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob Agents Chemother (2007) 0.94
Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother (2009) 0.94
Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae. Diagn Microbiol Infect Dis (2013) 0.93
Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Front Microbiol (2013) 0.93
Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother (2014) 0.91
Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves. J Dairy Sci (2014) 0.91
Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone. PLoS One (2015) 0.91
Clinical management of infections caused by multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis (2013) 0.88
Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico. Front Microbiol (2013) 0.87
Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant. PLoS One (2009) 0.87
Clinical importance and epidemiology of quinolone resistance. Infect Chemother (2014) 0.86
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents Chemother (2007) 0.86
Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis (2011) 0.85
Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. J Infect Dis (2012) 0.84
The structure of LpxD from Pseudomonas aeruginosa at 1.3 Å resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.84
Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother (2008) 0.84
Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans. EBioMedicine (2015) 0.84
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets. J Transl Med (2014) 0.84
Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure. PLoS One (2011) 0.84
Epidemiology of plasmid-mediated quinolone resistance in salmonella enterica serovar typhimurium isolates from food-producing animals in Japan. Gut Pathog (2010) 0.84
Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob Agents Chemother (2011) 0.83
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor. Antimicrob Agents Chemother (2015) 0.83
Interactions between QnrB, QnrB mutants, and DNA gyrase. Antimicrob Agents Chemother (2015) 0.83
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2010) 0.83
Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy. Infect Drug Resist (2011) 0.83
Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece. Antimicrob Agents Chemother (2008) 0.83
Amino acid substitutions in GyrA of Burkholderia glumae are implicated in not only oxolinic acid resistance but also fitness on rice plants. Appl Environ Microbiol (2006) 0.82
Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One (2014) 0.82
Characterization of fluoroquinolone resistance and qnr diversity in Enterobacteriaceae from municipal biosolids. Front Microbiol (2013) 0.82
In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B. Antimicrob Agents Chemother (2010) 0.82
Mechanisms of antimicrobial resistance in finfish aquaculture environments. Front Microbiol (2013) 0.81
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteria. Antimicrob Agents Chemother (2014) 0.80
The Three Bacterial Lines of Defense against Antimicrobial Agents. Int J Mol Sci (2015) 0.79
Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones. Diagn Microbiol Infect Dis (2013) 0.79
The prevalence of gene duplications and their ancient origin in Rhodobacter sphaeroides 2.4.1. BMC Microbiol (2010) 0.79
Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells. Antimicrob Agents Chemother (2009) 0.79
Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals. Can J Infect Dis Med Microbiol (2012) 0.79
Fluoroquinolone resistance during 2000-2005: an observational study. BMC Infect Dis (2008) 0.79
Molecular analysis of ciprofloxacin resistance mechanisms in Malaysian ESBL-producing Klebsiella pneumoniae isolates and development of mismatch amplification mutation assays (MAMA) for rapid detection of gyrA and parC mutations. Biomed Res Int (2014) 0.79
Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa. PLoS One (2009) 0.78
Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp. Front Microbiol (2015) 0.78
Reducing Vibrio load in Artemia nauplii using antimicrobial photodynamic therapy: a promising strategy to reduce antibiotic application in shrimp larviculture. Microb Biotechnol (2011) 0.78
In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens. Antimicrob Agents Chemother (2015) 0.78
AmpC beta-lactamases. Clin Microbiol Rev (2009) 7.14